$9.14
0.455.18%
At close: -
$9.13
-0.01000-0.11%
After Hours: 5:32 PM EDT
Comments
Loading...
Organon Analyst Ratings and Price Targets | NYSE:OGN | Benzinga
Organon & Co has a consensus price target of $21.43 based on the ratings of 7 analysts. The high is $33 issued by Raymond James on March 16, 2023. The low is $10 issued by Morgan Stanley on May 5, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, Morgan Stanley, and Morgan Stanley on May 15, 2025, May 5, 2025, and April 9, 2025, respectively. With an average price target of $14.33 between Piper Sandler, Morgan Stanley, and Morgan Stanley, there's an implied 56.99% upside for Organon & Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Morgan Stanley
Barclays
JP Morgan
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Organon
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2025 | Buy Now | 97.15% | Piper Sandler | David Amsellem77% | $24 → $18 | Maintains | Overweight | Get Alert |
| 05/05/2025 | Buy Now | 9.53% | Morgan Stanley | Terence Flynn64% | $15 → $10 | Maintains | Equal-Weight | Get Alert |
| 04/09/2025 | Buy Now | 64.29% | Morgan Stanley | Terence Flynn64% | $16 → $15 | Maintains | Equal-Weight | Get Alert |
| 02/14/2025 | Buy Now | 162.87% | Barclays | Balaji Prasad54% | $26 → $24 | Maintains | Overweight | Get Alert |
| 02/14/2025 | Buy Now | 75.25% | Morgan Stanley | Terence Flynn64% | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 09/06/2024 | Buy Now | 119.06% | JP Morgan | Chris Schott59% | $18 → $20 | Downgrade | Neutral → Underweight | Get Alert |
| 05/06/2024 | Buy Now | 119.06% | Goldman Sachs | Chris Shibutani54% | $18 → $20 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 119.06% | Goldman Sachs | Chris Shibutani54% | $18 → $20 | Maintains | Neutral | Get Alert |
| 04/29/2024 | Buy Now | 162.87% | Piper Sandler | David Amsellem77% | $22 → $24 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | 97.15% | Goldman Sachs | Chris Shibutani54% | $16 → $18 | Maintains | Neutral | Get Alert |
| 11/22/2023 | Buy Now | 140.96% | Piper Sandler | David Amsellem77% | $32 → $22 | Maintains | Overweight | Get Alert |
| 11/03/2023 | Buy Now | 75.25% | Goldman Sachs | Chris Shibutani54% | $33 → $16 | Downgrade | Buy → Neutral | Get Alert |
| 10/25/2023 | Buy Now | 250.49% | Piper Sandler | David Amsellem77% | $33 → $32 | Maintains | Overweight | Get Alert |
| 10/11/2023 | Buy Now | 140.96% | Morgan Stanley | Terence Flynn64% | $27 → $22 | Maintains | Equal-Weight | Get Alert |
| 09/21/2023 | Buy Now | 206.68% | Barclays | Balaji Prasad54% | → $28 | Initiates | → Overweight | Get Alert |
| 08/09/2023 | Buy Now | 195.73% | Morgan Stanley | Terence Flynn64% | $25 → $27 | Maintains | Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 173.82% | Morgan Stanley | Terence Flynn64% | $26 → $25 | Maintains | Equal-Weight | Get Alert |
| 03/16/2023 | Buy Now | 261.45% | Raymond James | Elliot Wilbur45% | → $33 | Initiates | → Outperform | Get Alert |
| 11/04/2022 | Buy Now | 162.87% | Morgan Stanley | Terence Flynn64% | $27 → $24 | Maintains | Equal-Weight | Get Alert |
| 10/14/2022 | Buy Now | 173.82% | B of A Securities | Jason Gerberry59% | $37 → $25 | Downgrade | Neutral → Underperform | Get Alert |
| 10/12/2022 | Buy Now | 195.73% | Morgan Stanley | Terence Flynn64% | $35 → $27 | Maintains | Equal-Weight | Get Alert |
| 09/06/2022 | Buy Now | 272.4% | Piper Sandler | David Amsellem77% | $37 → $34 | Upgrade | Neutral → Overweight | Get Alert |
| 08/05/2022 | Buy Now | 305.26% | B of A Securities | Jason Gerberry59% | $40 → $37 | Downgrade | Buy → Neutral | Get Alert |
| 07/08/2022 | Buy Now | 272.4% | Morgan Stanley | Terence Flynn64% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Organon (OGN) stock?
The latest price target for Organon (NYSE:OGN) was reported by Piper Sandler on May 15, 2025. The analyst firm set a price target for $18.00 expecting OGN to rise to within 12 months (a possible 97.15% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Organon (OGN)?
The latest analyst rating for Organon (NYSE:OGN) was provided by Piper Sandler, and Organon maintained their overweight rating.
When was the last upgrade for Organon (OGN)?
The last upgrade for Organon & Co happened on September 6, 2022 when Piper Sandler raised their price target to $34. Piper Sandler previously had a neutral for Organon & Co.
When was the last downgrade for Organon (OGN)?
The last downgrade for Organon & Co happened on September 6, 2024 when JP Morgan changed their price target from $18 to $20 for Organon & Co.
When is the next analyst rating going to be posted or updated for Organon (OGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organon was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.
Is the Analyst Rating Organon (OGN) correct?
While ratings are subjective and will change, the latest Organon (OGN) rating was a maintained with a price target of $24.00 to $18.00. The current price Organon (OGN) is trading at is $9.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
